Management of retinoblastoma during the Covid-19 pandemic: Experience at a tertiary care centre

Read full text Summarise with VIRAT
Authors: YOGITA GUPTA, Neiwete Lomi, Nimmy Raj, Alisha Kishore, RADHIKA TANDON
Cited by: 0
References: 3

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background Covid-19 disease and the imposed lockdown adversely affected patient care at healthcare facilities worldwide. Children affected with retinoblastoma require uninterrupted care due to systemic immunosuppression and the chances of disease relapse. We evaluated the impact of Covid-19 on patients with retinoblastoma and report a strategy to mitigate this impact. Methods We reviewed records of patients attending the ophthalmic emergency from March 2020 to March 2021. Patients with retinoblastoma were categorized based on their urgency level, and managed as per the treatment protocol. The relevant demographic data, clinical profile, referral details, and management strategy used were recorded and analysed. Results Fifty patients with retinoblastoma were reviewed (males 31 [62%], mean age 3.33 years). After Covid-19 screening, an ophthalmic examination was done, and an ocular diagnosis was established. The categorization was: 1 emergent, 21 urgent, 26 semi-urgent, and 2 non-urgent patients. Of the 47 patients tested for Covid-19, two were positive and the intervention was deferred. An intervention was delivered in 41 patients (1 orbital biopsy, 9 enucleation, 27 focal therapy, 4 systemic chemotherapy), and 9 received no intervention. A 78.7% reduction in new patients was seen in attendance of the retinoblastoma clinic (p=0.02). All healthcare professionals used personal protective equipment. Teleconsultations were encouraged wherever possible. Support of non-governmental organizations was sought for patient mobilization. Conclusion The described model exemplifies a strategy to mitigate the impact of Covid-19 and lockdown on healthcare delivery to patients with retinoblastoma for a year.

Fields of Study & Subjects

COVID-19 and healthcare impacts Ocular Oncology and Treatments Retinal and Optic Conditions

Publication details

Journal / source
The National Medical Journal of India
Volume
39
Issue
3
Pages
150–153
Publication date
25 March 2026
Language
EN